Literature DB >> 23943615

Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway.

Cheng Qian1, Li Qian, Yizhi Yu, Huazhang An, Zhenhong Guo, Yanmei Han, Yongjian Chen, Yi Bai, Qingqing Wang, Xuetao Cao.   

Abstract

Dendritic cells (DCs) play important roles in the initiation of immune response and also in the maintenance of immune tolerance. Now, many kinds of regulatory DCs with different phenotypes have been identified to suppress immune response and contribute to the control of autoimmune diseases. However, the mechanisms by which regulatory DCs can be regulated to exert the immunosuppressive function in the immune microenvironment remain to be fully investigated. In addition, how T cells, once activated, can feedback affect the function of regulatory DCs during immune response needs to be further identified. We previously identified a unique subset of CD11b(hi)Ia(low) regulatory DCs, differentiated from mature DCs or hematopoietic stem cells under a stromal microenvironment in spleen and liver, which can negatively regulate immune response in a feedback way. Here, we show that CD11b(hi)Ia(low) regulatory DCs expressed high level of Fas, and endothelial stromal cell-derived TGF-β could induce high expression of Fas on regulatory DCs via ERK activation. Fas ligation could promote regulatory DCs to inhibit CD4(+) T cell proliferation more significantly. Furthermore, Fas ligation preferentially induced regulatory DCs to produce IL-10 and IP-10 via ERK-mediated inactivation of GSK-3 and subsequent up-regulation of β-catenin. Interestingly, activated T cells could promote regulatory DCs to secrete more IL-10 and IP-10 partially through FasL. Therefore, our results demonstrate that Fas signal, at least from the activated T cells, can promote the immunosuppressive function of Fas-expressing regulatory DCs, providing a new manner for the regulatory DCs to regulate adaptive immunity.

Entities:  

Keywords:  Catenin; Dendritic Cells; ERK; Fas; Tolerance

Mesh:

Substances:

Year:  2013        PMID: 23943615      PMCID: PMC3784698          DOI: 10.1074/jbc.M112.425751

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  CD40/CD154 interactions at the interface of tolerance and immunity.

Authors:  Sergio A Quezada; Lamis Z Jarvinen; Evan F Lind; Randolph J Noelle
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

2.  Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells.

Authors:  Minghui Zhang; Hua Tang; Zhenhong Guo; Huazhang An; Xuejun Zhu; Wengang Song; Jun Guo; Xin Huang; Taoyong Chen; Jianli Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2004-10-10       Impact factor: 25.606

3.  Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells.

Authors:  X R Li; A S Chong; J Wu; K A Roebuck; A Kumar; J E Parrillo; U R Rapp; R P Kimberly; J W Williams; X Xu
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  Fas (CD95, APO-1) antigen expression and function in murine mast cells.

Authors:  K Hartmann; A L Wagelie-Steffen; E von Stebut; D D Metcalfe
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

5.  Inhibition of MEK induces fas expression and apoptosis in lymphomas overexpressing Ras.

Authors:  Wojciech Kalas; Pawel Kisielow; Leon Strzadala
Journal:  Leuk Lymphoma       Date:  2002-07

6.  TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.

Authors:  H Strobl; E Riedl; C Scheinecker; C Bello-Fernandez; W F Pickl; K Rappersberger; O Majdic; W Knapp
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

Review 7.  Induction of tolerance using Fas ligand: a double-edged immunomodulator.

Authors:  Nadir Askenasy; Esma S Yolcu; Isaac Yaniv; Haval Shirwan
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

8.  Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways.

Authors:  Zhenhong Guo; Minghui Zhang; Huazhang An; Weilin Chen; Shuxun Liu; Jun Guo; Yizhi Yu; Xuetao Cao
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

9.  Glycogen synthase kinase-3beta is tyrosine-phosphorylated by MEK1 in human skin fibroblasts.

Authors:  Fumi Takahashi-Yanaga; Fumie Shiraishi; Masato Hirata; Yoshikazu Miwa; Sachio Morimoto; Toshiyuki Sasaguri
Journal:  Biochem Biophys Res Commun       Date:  2004-04-02       Impact factor: 3.575

10.  Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.

Authors:  K Hughes; E Nikolakaki; S E Plyte; N F Totty; J R Woodgett
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  19 in total

Review 1.  Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.

Authors:  Daniel Swafford; Santhakumar Manicassamy
Journal:  Discov Med       Date:  2015-04       Impact factor: 2.970

Review 2.  Tolerogenic dendritic cells and their applications in transplantation.

Authors:  Haibin Li; Bingyi Shi
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

3.  Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

Authors:  Dragana Odobasic; Virginie Oudin; Kenji Ito; Poh-Yi Gan; A Richard Kitching; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2019-08-23       Impact factor: 10.121

Review 4.  The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Authors:  K Sanjana P Devi; Niroshana Anandasabapathy
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

Review 5.  Immunosuppressive cells in tumor immune escape and metastasis.

Authors:  Yang Liu; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2015-12-22       Impact factor: 4.599

6.  β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10.

Authors:  Chunmei Fu; Xinjun Liang; Weiguo Cui; Julia L Ober-Blöbaum; Joseph Vazzana; Protul A Shrikant; Kelvin P Lee; Björn E Clausen; Ira Mellman; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

7.  Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.

Authors:  Qiuyan Liu; Qinchun Tan; Yuanyuan Zheng; Kun Chen; Cheng Qian; Nan Li; Qingqing Wang; Xuetao Cao
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

Review 8.  Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer.

Authors:  Amol Suryawanshi; Raghu K Tadagavadi; Daniel Swafford; Santhakumar Manicassamy
Journal:  Front Immunol       Date:  2016-10-27       Impact factor: 7.561

9.  Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.

Authors:  Wen-Xiang Gao; Yue-Qi Sun; Jianbo Shi; Cheng-Lin Li; Shu-Bin Fang; Dan Wang; Xue-Quan Deng; Weiping Wen; Qing-Ling Fu
Journal:  Stem Cell Res Ther       Date:  2017-03-02       Impact factor: 6.832

10.  In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae.

Authors:  L Zhang; T Zhang; L Wang; S Shao; Z Chen; Z Zhang
Journal:  Gene Ther       Date:  2014-05-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.